Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. JXN
JXN logo

JXN Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Jackson Financial Inc (JXN) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
105.720
1 Day change
2.65%
52 Week Range
123.610
Analysis Updated At
2026/03/27
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

Jackson Financial Inc (JXN) is not a strong buy for a beginner, long-term investor at this moment. While the stock shows some positive technical indicators and hedge fund buying, the company's financial performance is weak, with significant declines in net income and EPS. Additionally, the options data reflects bearish sentiment, and there are no strong catalysts or recent positive news to support a buy decision.

Technical Analysis

The MACD is positive and expanding (0.265), indicating a bullish trend. RSI is neutral at 50.521, and moving averages are converging, showing no clear directional bias. The stock is trading near its pivot level (105.006), with resistance at 108.079 and support at 101.932.

Options Data

Bearish
Open Interest Put-Call Ratio
Bearish
Option Volume Put-Call Ratio

The high option volume put-call ratio (5.28) suggests bearish sentiment, with significantly more put volume than call volume. Implied volatility is at 42.32, with a 65.34 percentile, indicating moderate uncertainty.

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
4
Buy
7

Positive Catalysts

  • Hedge funds are aggressively buying, with a 1444.89% increase in buying activity over the last quarter. Analysts have provided some optimistic price targets, with Barclays setting a $137 target and maintaining an Overweight rating.

Neutral/Negative Catalysts

  • The company's financials for Q4 2025 show a significant decline in net income (-164.37% YoY) and EPS (-170.56% YoY). There is no recent news or event-driven catalysts to support a bullish case. Options data reflects bearish sentiment, and insider trading is neutral.

Financial Performance

In Q4 2025, revenue increased significantly by 524.60% YoY to $1.955 billion. However, net income dropped to -$215 million (-164.37% YoY), and EPS declined to -3.14 (-170.56% YoY), indicating poor profitability and operational challenges.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Analysts have mixed views. Barclays raised its price target to $137 with an Overweight rating, while Evercore ISI upgraded the stock to In Line with a $118 target. Keefe Bruyette re-initiated coverage with a Market Perform rating and a $123 target, citing mixed fundamentals in the life insurance sector.

Wall Street analysts forecast JXN stock price to rise
5 Analyst Rating
Wall Street analysts forecast JXN stock price to rise
1 Buy
4 Hold
0 Sell
Hold
Current: 102.990
sliders
Low
100
Averages
115
High
137
Current: 102.990
sliders
Low
100
Averages
115
High
137
Keefe Bruyette
Market Perform
initiated
$123
AI Analysis
2026-03-26
Reason
Keefe Bruyette
Price Target
$123
AI Analysis
2026-03-26
initiated
Market Perform
Reason
Keefe Bruyette re-initiated coverage of Jackson Financial with a Market Perform rating and $123 price target. The life insurance sector presents a mixed fundamental picture, and while companies have reduced liability tail risk, improved free cash flow conversion, and benefited from stronger growth, they face intensifying competition, rising investment leverage, greater balance sheet complexity, and eventual fading macro tailwinds, the analyst tells investors in a research note.
Barclays
NULL -> Overweight
maintain
$128 -> $137
2026-01-08
Reason
Barclays
Price Target
$128 -> $137
2026-01-08
maintain
NULL -> Overweight
Reason
Barclays raised the firm's price target on Jackson Financial to $137 from $128 and keeps an Overweight rating on the shares. The firm is "cautiously optimistic" on life insurers heading into 2026, saying capital strength, cash flow, and consolidation offset headwinds like spread compression and technology spend. Barclays adjusted ratings and price targets as part of its 2026 outlook.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for JXN
Unlock Now

People Also Watch